Collegium Pharmaceutical, Inc. COLL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s restricted cash?
- Collegium Pharmaceutical, Inc. (COLL) reported restricted cash of $19.85M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s restricted cash changed year-over-year?
- Collegium Pharmaceutical, Inc.'s restricted cash decreased by 0.0% year-over-year, from $19.86M to $19.85M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s restricted cash has grown at a 50.8% compound annual growth rate (CAGR), from $2.55M to $19.85M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.